Multiple Sclerosis Drugs Market to Reach USD 39.7 Billion by 2036,...

Ajouter une nouvelle offre d'emploi Autre

2026-06-25 10:08:55 -

Multiple Sclerosis Drugs Market to Reach USD 39.7 Billion by 2036, Driven by Rising MS Prevalence and Growing Adoption of High-Efficacy Disease-Modifying Therapies

Multiple Sclerosis Drugs Market Overview Multiple sclerosis (MS) drugs are therapeutic agents used to manage multiple sclerosis, a chronic autoimmune disease that affects the central nervous system. These therapies include disease-modifying treatments (DMTs), biologics, oral medications, and injectable therapies designed to reduce relapse rates, slow disease progression, and improve patient...

0 Commentaires 0 Parts 4 Vue 0 Aperçu